Covid-19, vagus nerve and phrenic nerve: three sides to the same story
Reference34 articles.
1. Farsalinos, K., Bagos, P. G., Giannouchos, T., Niaura, R., Barbouni, A., & Poulas, K. (12 2021). Smoking prevalence among hospitalized COVID-19 patients and its association with disease severity and mortality: an expanded re-analysis of a recent publication. Harm Reduction Journal, vol. 18. doi:10.1186/s12954-020-00437-5 2. Tsigaris, P., & Teixeira da Silva, J. A. (8 2020). Smoking Prevalence and COVID-19 in Europe. Nicotine & Tobacco Research, vol. 22, pp. 1646–1649. doi:10.1093/ntr/ntaa121 3. Fowler, C. D., Turner, J. R., & Imad Damaj, M. (2019). Molecular Mechanisms Associated with Nicotine Pharmacology and Dependence. Substance Use Disorders, pp. 373–393. doi:10.1007/164_2019_252 4. Alexandris, N., Lagoumintzis, G., Chasapis, C. T., Leonidas, D. D., Papadopoulos, G. E., Tzartos, S. J., … Farsalinos, K. (2021). Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions. Toxicology Reports, vol. 8, pp. 73–83. doi:10.1016/j.toxrep.2020.12.013 5. Tanmay, S., Labrou, D., Farsalinos, K., & Poulas, K. (6 2021). Is SARS-CoV-2 Spike glycoprotein impairing macrophage function via α7-nicotinic acetylcholine receptors? Food and Chemical Toxicology, vol. 152, p. 112184. doi:10.1016/j.fct.2021.112184
|
|